Is TB-500 Legal in Minnesota? How to Access It Legally

HealthRX.com

Minnesota rules are not in the federal records

Print or save as PDF

See the public record for TB-500

  • FDA approval / None; no FDA-approved drug contains TB-500 [1]
  • Compounding list / Not in category 1, 2, or 3 for state-licensed compounding [2][4]
  • Advisory vote / July 23, 2026 vote favored adding it; non-binding [5][3]
  • HHS draft policy / Names TB-500; draft enforcement discretion only, not binding [3][6]
  • Human data / None found; no study gave TB-500 to a person [1]
  • Sport / WADA prohibits TB-500 at all times [7][8]

Is TB-500 legal in Minnesota?

No Minnesota statute, board rule or prescriber rule is available to confirm whether or how TB-500 can be obtained in Minnesota. Federally, TB-500 is not an FDA-approved drug and is not on FDA's bulk-substance list for state-licensed compounding [1][2]. It is a synthetic 7-amino-acid fragment of the 43-amino-acid protein thymosin beta-4, not full-length thymosin beta-4 [1].

Questions worth asking

Choose the questions you want to keep

What is the federal compounding status?

FDA's July 2026 review found no USP or National Formulary monograph for TB-500 and no FDA-approved drug containing it [1].

TB-500 is not in any of the three categories on FDA's list for state-licensed pharmacies and physicians, and it is not on FDA's outsourcing-facility list [2][9][4]. FDA's category 1 policy does not cover it [2][4]. On FDA's safety-risk page, it sits in the 'nominated but withdrawn' table, not the active category 2 table [10]. Removal from category 2 was not a finding that it is safe.

FDA staff proposed in July 2026 that neither TB-500 free base nor TB-500 acetate be added to the pharmacy bulks list, citing no human data, no effectiveness evidence for wound healing, and immunogenicity risk [1]. The Pharmacy Compounding Advisory Committee voted on July 23, 2026 in favor of adding it, against FDA staff's recommendation; the vote is advice only and not binding [5][3]. TB-500 is not on the list, and adding it requires formal rulemaking [3].

What does the HHS draft policy say?

HHS filed a draft enforcement-discretion policy for certain peptides on October 28, 2026, with publication scheduled for October 30, 2026 and comments due two weeks after publication [3]. It names TB-500 among six peptides and covers TB-500 acetate given by subcutaneous or intramuscular injection [3][6]. HHS says it 'does not intend to take enforcement action' against a state-licensed pharmacy, federal facility, or licensed physician compounding with it if conditions are met, such as a single active ingredient, a patient-specific prescription, an FDA-registered manufacturer with a certificate of analysis, and the label 'This is a compounded drug product. Not for resale.' [3][6]

That is the whole of what the draft does. It is not FDA approval and does not put TB-500 on any list, and the notice says it 'does not establish any rights for any person and is not binding on HHS or the public,' with HHS free to revisit it after a safety signal or product-quality issue [3]. Compounded drugs are not FDA-approved; FDA does not review their safety, effectiveness, or quality before marketing [3][11].

What is sold online, and what is known about dosing?

FDA found no pharmacy marketing a compounded TB-500 product and no outsourcing facility reporting one [1]. Injectable powder sold online as 'research use only' comes in 2 mg to 15 mg vials, alone or blended with BPC-157 [1]. FDA found no human pharmacokinetic or pharmacodynamic data and no human dosing study for TB-500; the nomination FDA reviewed proposed a 3 mg/mL lyophilized powder for subcutaneous or intramuscular injection, which is a proposal, not a recommended dose [1].

What about athletes?

WADA names 'Thymosin-beta4 and its derivatives e.g. TB-500' in S2.3 (growth factors and growth factor modulators) [7]. It is prohibited at all times, in and out of competition, on the 2026 List and stays on the 2027 List [7][8].

Check what you know

Think you have it? Try 3 quick questions and see what the article says.

1. Which description of the 7-amino-acid peptide in the article is correct?

Question 1 of 3

Score: 0 right, 0 of 3 answered

Is TB-500 legal in Minnesota?
Federal records do not settle Minnesota's rules. Federally, TB-500 is not FDA-approved or on FDA's compounding bulks list, and HHS's draft policy does not create an access route [1][2][3].
Is TB-500 FDA-approved?
No. FDA's July 2026 review found no approved drug containing TB-500 and no USP or National Formulary monograph for it [1].
Does the July 2026 advisory vote make TB-500 legal?
No. The advisory vote did not add TB-500 to the compounding list, and HHS's draft policy is not binding [5][3].
Can a pharmacy compound TB-500?
Federally, TB-500 is not on the compounding list, and FDA's category 1 policy does not cover it [2][4]. HHS's draft, non-binding policy says it does not intend to take enforcement action against patient-specific TB-500 acetate compounding by state-licensed pharmacies, federal facilities and licensed physicians that meet its conditions [3][6].
Is TB-500 banned in sport?
Yes. WADA names thymosin-beta4 and its derivatives, e.g. TB-500, in S2.3 and prohibits them at all times [7][8].
Show all 11 referencesHide references
Evidence overview for Is TB-500 Legal in Minnesota? How to Access It Legally